The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer.

CONCLUSIONS: A statistically significant difference in breast cancer specific survival is seen in groups defined using Ki67 and receptor status, whereas histological grading was not a significant predictor of survival. Ki67 immunostaining provides prognostic information beyond traditionally assessed clinicopathological variables.
PMID: 24403187 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - January 8, 2014 Category: Cancer & Oncology Authors: Pathmanathan N, Balleine RL, Jayasinghe UW, Bilinski KL, Provan PJ, Byth K, Bilous AM, Salisbury EL, Boyages J Tags: J Clin Pathol Source Type: research